Skip to main content
logo
Redsense Medical AB (publ) (XSAT:REDS)
Sweden flag Sweden · Delayed Price · Currency is SEK
3.390
+0.090 (2.73%)
At close: Mar 18, 2026

Redsense Medical AB Income Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
26.828.7725.5216.7516.34
Other Revenue
-0--0-
Revenue
26.828.7725.5216.7516.34
Revenue Growth (YoY)
-6.84%12.74%52.32%2.51%-4.43%
Cost of Revenue
11.2410.6912.365.495.95
Gross Profit
15.5618.0813.1611.2710.4
Selling, General & Admin
18.6619.7617.5422.4622.77
Other Operating Expenses
3.65-1.960.59-1.04-0.56
Operating Expenses
22.9317.8718.221.4722.39
Operating Income
-7.370.21-5.04-10.21-11.99
Interest Expense
--0.04-0.03-0.1-0.05
Interest & Investment Income
0.20.170.061.021.05
Earnings From Equity Investments
-----0.3
Currency Exchange Gain (Loss)
---2.5-
Other Non Operating Income (Expenses)
-0---00
EBT Excluding Unusual Items
-7.170.34-5.01-6.79-11.29
Gain (Loss) on Sale of Investments
--0.5-1.973.32
Pretax Income
-7.170.34-4.51-8.76-7.97
Net Income
-7.170.34-4.51-8.76-7.97
Net Income to Common
-7.170.34-4.51-8.76-7.97
Shares Outstanding (Basic)
1617141414
Shares Outstanding (Diluted)
1617141414
Shares Change (YoY)
-3.83%21.25%-0.16%0.60%-
EPS (Basic)
0.440.02-0.32-0.62-0.57
EPS (Diluted)
0.440.02-0.32-0.62-0.57
EPS Growth
2100.00%----
Free Cash Flow
-5.24-8.25-5.1-9.83-12.58
Free Cash Flow Per Share
-0.32-0.48-0.36-0.70-0.90
Gross Margin
58.07%62.83%51.56%67.24%63.63%
Operating Margin
-27.48%0.73%-19.74%-60.93%-73.37%
Profit Margin
-26.76%1.19%-17.69%-52.27%-48.78%
Free Cash Flow Margin
-19.54%-28.66%-20.00%-58.68%-76.98%
EBITDA
-6.740.28-4.98-10.16-11.97
EBITDA Margin
-25.14%0.96%-19.50%-60.61%-73.21%
D&A For EBITDA
0.630.070.060.050.03
EBIT
-7.370.21-5.04-10.21-11.99
EBIT Margin
-27.48%0.73%-19.74%-60.93%-73.37%
Revenue as Reported
26.832.6325.5617.7916.9
Source: S&P Global Market Intelligence. Standard template. Financial Sources.